BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12794243)

  • 1. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
    Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors.
    Satoh K; Kaneko K; Hirota M; Masamune A; Satoh A; Shimosegawa T
    Cancer; 2001 Jul; 92(2):271-8. PubMed ID: 11466679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
    Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
    Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
    Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
    Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
    Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas.
    Yamaguchi K; Ohuchida J; Ohtsuka T; Nakano K; Tanaka M
    Pancreatology; 2002; 2(5):484-90. PubMed ID: 12378117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis.
    Kawasaki H; Toyoda M; Shinohara H; Okuda J; Watanabe I; Yamamoto T; Tanaka K; Tenjo T; Tanigawa N
    Cancer; 2001 Jun; 91(11):2026-32. PubMed ID: 11391581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.
    Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
    Ansari D; Aronsson L; Andersson R
    Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
    [No Abstract]   [Full Text] [Related]  

  • 13. Xanthogranulomatous pancreatitis combined with intraductal papillary mucinous carcinoma in situ.
    Kim YN; Park SY; Kim YK; Moon WS
    J Korean Med Sci; 2010 Dec; 25(12):1814-7. PubMed ID: 21165301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.